4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-23-045156
EVP, Chief Financial Officer sold 35,125 shares at $9.73 ($341,889)
From the SEC's structured data for this filing
Trades in this filing
Kalif Eliyahu Sharon · EVP, Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-07 | Sale : show line 1 in the form | −35,125 | $9.73 | $341,889 | 99,162 | D |
| Open-market sales · 35,125 sh · avg $9.73 · $341,889 | ||||||
Loading xslF345X05/doc4.xml…